Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Newly Merged Mitsubishi Tanabe Ranks Fourth In Japan Market

This article was originally published in PharmAsia News

Executive Summary

Less than a year after it was created in a merger, Mitsubishi Tanabe has become Japan's fourth largest drug maker in terms of market share for prescription drugs. Formed by the combination of Mitubishi Pharma and Tanabe Seiyaku, the new firm held 4.9 percent of the market in fiscal 2007, although it was 0.2 percent less than combined share of the separate firms the previous year. Takeda Pharmaceutical with 8 percent, Astellas Pharma at 7.3 percent and Daiichi Sankyo with 6.3 percent repeated as the top three. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts